Device Trial Radar · NCT01448382
Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study
Last checked: Nov 19, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
39
Actual
Start
Oct 2011
Primary completion
Dec 2015
Study completion Dec 2015
Sponsor
- Lead sponsor
- Medtronic - MITGPublic (MDT)
- Sponsor type
- Industry
- First posted
- Oct 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
1. Primary Scientific Objective * Collect human clinical data to sustain the development of blood detection sensor and optimize its algorithm and parameters * Preliminary evaluation of blood detection performances in human. 2. Secondary Scientific Objective * Assessment of blood detection sensor ability to identify the anatomical location (i.e. Stomach, SB or Colon) * Evaluation of capsule transit characteristics in the GI tract * Evaluation of BBC capsule safety Study Hypothesis: It is estimated that by implementing a spectrophotometer technology in capsule and utilizing the unique characteristics of light absorption by blood in specific spectrum, the capsule will be able to automatically detect blood in the GI tract with high accuracy. As such, the system may be an add-on to video capsules to provide efficient and quick detection of blood presence (for example in OGBI patients) or as stand alone low cost capsule (without video) which could serve as a tool similar to standard FOBT.
Conditions
- Upper GI Bleeding
Interventions
PillCam® capsule with Given PillCam® PlatformDevice
capsule endoscopy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Agreement level between the blood detectors head to capsule video head in detecting subjects with blood in the GI tractTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rambam medical center
Haifa, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.